Physician profile
Amy Dee Pruszenski
NPI 1174559348
$1,452.56
in general payments reported to CMS, 2019-2025
12 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Pediatrics (Optometrist) provider received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $127 · 2021: $180 · 2022: $148 · 2023: $268 · 2024: $173 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $379.59 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $316.38 | 2023-2025 | Infuse |
| Novartis Pharmaceuticals Corporation | $180.00 | 2019-2023 | |
| Amgen INC. | $145.14 | 2025 | Uplizna |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $116.41 | 2021 | |
| Alcon Vision LLC | $99.67 | 2019-2023 | Precision 1 |
| Lkc Technologies, INC. | $73.13 | 2023 | |
| Maculogix, INC. | $61.08 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $28.93 | 2024 | Xdemvy |
| Glaukos Corporation | $20.90 | 2024 | Radius |
| Shire North American Group INC | $16.61 | 2019 | |
| Allergan, INC. | $14.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Pruszenski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.